Table 1B.

Level of evidence and grading of therapeutic recommendations, according to criteria endorsed by EULAR/EUVAS6,24. From Dougados, et al. Ann Rheum Dis 2004;63:1172–6; with permission.

Strength of recommendation.

Strength of RecommendationDirectly Based on Level of Evidence
ACategory 1 evidence
BCategory 2 evidence or extrapolated recommendations from category 1 evidence.
CCategory 3 evidence or extrapolated recommendations from category 1 or 2 evidence.
DCategory 4 evidence or extrapolated recommendations from category 2 or 3 evidence.
  • EULAR: European League Against Rheumatism; EUVAS: European Vasculitis Society.